DANVERS, Mass., Oct. 19, 2017 (GLOBE NEWSWIRE) — Abiomed Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announces that there are more than 30 presentations potentially featuring the Impella® line of heart pumps scheduled during the 29th Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of […]
Other News
Avinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent Restenosis
REDWOOD CITY, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced initiation of INSIGHT, a prospective, global, single arm, multi-center study to evaluate the safety and effectiveness of the Pantheris® Lumivascular Atherectomy System for treating in-stent […]
BD Statement On European Commission Conditional Clearance Of Bard Acquisition
FRANKLIN LAKES, N.J., Oct. 18, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today’s clearance by the European Commission for BD to acquire C.R. Bard (NYSE: BCR), contingent on BD divesting its soft tissue core needle biopsy product line: “We […]
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within the emerging electrophysiology (EP) marketplace, announced today that they have made significant progress towards commercialization of their proprietary PURE EP System. The […]
HeartSciences Launches Breakthrough ECG Technology at the Canadian Cardiovascular Congress
MyoVista® hsECG™ Utilizes Wavelet Technology to Detect Cardiac Diastolic Dysfunction SOUTHLAKE, Texas, Oct. 19, 2017 /PRNewswire-USNewswire/ — HeartSciences announced today that the company will launch its MyoVista® high sensitivity electrocardiograph (hsECG™) Testing Device in Canada at the Canadian Cardiovascular Congress (CCC) in Vancouver on October 21-24. The MyoVista hsECG is now available in Canada, where it received Health Canada Medical […]
CytoSorb® Usage During Valve Replacement Surgery for Infective Endocarditis Helps Stabilize Patients and May Improve Survival
MONMOUTH JUNCTION, N.J., Oct. 19, 2017 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, highlights the largest endocarditis valve replacement study using CytoSorb published to date entitled, “Hemoadsorption treatment of patients with acute infective endocarditis during […]
HyperMed Imaging Announces Sales Availability for Its New HyperView Product
MEMPHIS, Tenn.–(BUSINESS WIRE)–HyperMed Imaging, Inc. announced today that the company is now offering for sale its new HyperView™ Imaging System to customers in the United States. Customers are invited to contact the company for more information. HyperMed will be present at the Symposium on Advanced Wound Care (SAWC) in Las Vegas, […]
Dassault Systèmes’ Living Heart Project Reaches Next Milestones in Mission to Improve Patient Care
HOLLYWOOD, Fla.–(BUSINESS WIRE)–Dassault Systèmes (Paris:DSY) (Euronext Paris: #13065, DSY.PA) today outlined, at the 3DEXPERIENCE Forum North America, multiple milestones in its Living Heart Project aimed to drive the creation and use of simulated 3D personalized hearts in the treatment, diagnosis and prevention of heart diseases. As the scientific and medical community seeks faster and more targeted […]
The Aging Population of Cardiologists and Potential Solutions
By Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) According to MedAxiom’s annual Cardiovascular Provider Compensation & Production survey 45 percent of all cardiologists in America are aged 56 or older and 20 percent over 61. So, with an aging population of cardiology practitioners we must ask, “how is this is being addressed?” Two […]
Creavo Medical Technologies secures U.S. FDA 510(k)
October 16, 2017 Rebecca Anderson Technology has the potential to revolutionise emergency department triage of chest pain patients. Developer of innovative medical diagnostic technology, Creavo Medical Technologies, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The move opens the U.S. market for its portable scanning device, Vitalscan, […]



